United States · Investor

Mediphase Venture Partners

Last cheque observed Jul 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $349K, Feb 2012VC firm

Series CSeries ASeries DDatabaseInternet

Cheques on record
0%of best year0cheques in 12 months, 16 on record
Since the last cheque5230days00hrs00min00sec
Median round$26MRounds led0 of 16Exits3 from the portfolioMostly inUnited States, 100%
Pitch Mediphase Venture Partners

Mediphase Venture Partners highlights

  1. 01

    16 rounds on record

  2. 02

    Mostly Series C and Series A: 56% of its rounds

  3. 03

    3 exits from the portfolio

What they do

Filed 1 private fund offering with the SEC, the most recent in 2010-04From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
DatabaseInternet
Based in
Newton, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first16 appearances

  1. 2012

    1 round

  2. Jul
    RelypsaGrowth · US$62MWith 6 others
  3. 2010

    2 rounds

  4. Sept
    RelypsaSeries B · US · finsmes.com$70MWith 5 others
  5. Jun
    Tetraphase PharmaceuticalsSeries C · US · fiercebiotech.com$45MWith 7 others
  6. 2008

    3 rounds

  7. Aug
    Tetraphase PharmaceuticalsSeries A · US · equityhelpdesk.com$15MWith 4 others
  8. Aug
    WellpartnerSeries D · US$16MWith 5 others
  9. Apr
    Concert PharmaceuticalsSeries C · US$37MWith 11 others
  10. 2007

    3 rounds

  11. Oct
    RelypsaSeries A · US · venturebeat.com$33MWith 5 others
  12. Jun
    SerenexSeries D · US$26MWith 9 others
  13. Mar
    WellpartnerSeries C · US$7.5MWith 4 others
  14. 2006

    2 rounds

  15. Nov
    Tetraphase PharmaceuticalsSeries A · US$10MWith 4 others
  16. Jun
    PatientKeeperVenture · US · patientkeeper.com$8.0MWith 6 others
  17. 2005

    1 round

  18. Oct
    SerenexSeries C · US$30MWith 5 others
  19. 2004

    2 rounds

  20. Jul
    Vitra BioscienceSeries B · US$5.5MWith 3 others
  21. Jun
    PatientKeeperSeries D · US$7.0MWith 5 others
  22. 2002

    1 round

  23. May
    ImpactRxSeries C · USUndisclosedWith 1 other
  24. 2000

    1 round

  25. Aug
    PatientKeeperSeries C · US$43MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

DCDavid C. LubnerPrincipal of the Issuer's General Partner and Manager.iFiling they signed
LGLawrence G. MillerFounder and principal of the Issuer's General Partner and Manager.iFiling they signed
PAPaul A. HowardFounder and principal of the Issuer's General Partner and Manager.iFiling they signed

We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

PatientKeeperBought by HCAUndisclosedSept 2014
ImpactRxBought by Symphony Technology GroupUndisclosedApr 2011
SerenexBought by PfizerUndisclosedMar 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Mediphase Venture Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Mediphase Venture Partners

What does Mediphase Venture Partners invest in?

Mediphase Venture Partners invests most often at Series C and Series A (56% of the rounds on record), in sectors such as Database and Internet.

How active is Mediphase Venture Partners?

16 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2012.

How big are Mediphase Venture Partners's cheques?

The median round it joins is $26M.

Does Mediphase Venture Partners lead rounds?

Rarely, if at all: none of its 16 investments on record names it as the lead.

Where does Mediphase Venture Partners invest?

Most of the companies it backs are in the United States (100%).

Is Mediphase Venture Partners investing now?

No investments in the last 12 months; the latest was in Jul 2012.

Who does Mediphase Venture Partners invest alongside?

Most often CMEA Ventures (4 rounds together), New Leaf Venture Partners (4 rounds together) and Skyline Ventures (4 rounds together).

What kind of investor is Mediphase Venture Partners?

Mediphase Venture Partners is a VC firm based in Newton, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it